← Eichor
Study identifier: NCT07130682 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial

Condition: Prostate Cancer Patients Treated by Radiotherapy  ·  Sponsor: Hong Kong Sanatorium & Hospital

PhaseNA
Planned participants35
Who can joinMale, N/A to no upper limit
Healthy volunteersNo

About this study

This study is testing a shorter treatment method for prostate cancer using proton therapy (PT), which is very precise and may cause fewer side effects compared to traditional radiation. However, it is expensive and not easily accessible for many patients. To make it more affordable and accessible, this study is testing whether 2 fractions of stereotactic body proton therapy (SBPT) can be as safe and effective as the standard 5 sessions.

This description comes directly from the study's public registry record.

Talk to the study team

Oi Lei Wong, Ph.D.  ·  1-852-2917 5550  ·  oilei.ol.wong@hksh.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hong Kong Sanatorium and HospitalHong Kong, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07130682